Linda Johnson

AP Business Writer
Latest in Home
I Stock 1396614976
J&J Says It Will Spend $2B to Expand Biopharmaceutical Manufacturing in U.S.
September 17, 2025
Investment Pr Header Image Abb Factory
ABB to Invest $110 Million in 4 U.S. Plants
September 17, 2025
Osha
Fall Protection Leads OSHA’s Top 10 Safety Violations for 15th Straight Year
September 17, 2025
CEO of Nvidia Jensen Huang speaks during a press conference at the Mandarin Oriental Qianmen after attending the third China International Supply Chain Expo, in Beijing, July 16, 2025.
Nvidia CEO Huang Says He's Disappointed by China Chip Curbs
September 17, 2025
Related Stories
Mnet 123114 Mexico Oil Parr
Chemical Processing
Mexico Will Defer Oil Exploration Projects to Slash Spending
Mnet 123113 Pacifierbaby
Chemical Processing
WHO: Chemical in Most Rubbers Linked to Cancer
Mnet 170636 Google Self Driving C Minn 1 0
Automotive
Google's Self-Driving Car Strikes Municipal Bus
Mnet 191159 Hero 6
Industry 4.0
MM Blog: Autonomous Cruise Missiles
More from Linda Johnson
This Feb. 24, 2021 photo shows a Johnson & Johnson logo on the exterior of a first aid kit in Walpole, Mass. Johnson & Johnson is recalling five of its sunscreen products after testing found low levels of benzene _ a chemical that can cause cancer with repeated exposure _ in some product samples, the company said late Wednesday, July 14, 2021.
Recalls
J&J Recalling Sunscreens Due to Benzene
It is investigating how the carcinogen got into the products.
July 14, 2021
In this file photo, a pharmacist holds a vial of the Johnson & Johnson COVID-19 vaccine.
Laws & Regulations
FDA Found Problems at J&J Vaccine Factory
The issues ranged from poorly trained employees to cracked vials to mold around one of its facilities.
April 21, 2021
President Joe Biden speaks about efforts to combat COVID-19, in the State Dining Room of the White House, Tuesday, March 2, 2021, in Washington.
Operations
Biden Vows Enough Vaccine for All US Adults by End of May
Biden’s announcements quickly raised expectations for when the nation could safely emerge from the pandemic.
March 3, 2021
Mike McDermott, president of global supply since 2019.
Supply Chain
Insider Q&A: Pfizer Exec on Ramping Up Vaccine Supply
"We look at reducing wait times when changing over between batches, doubling of our batch size, increasing yields per batch."
February 15, 2021
This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine.
Safety
J&J 1-Dose Shot Works, Less Effective Than Others
It appears to protect against COVID-19, but not as strongly as some two-shot rivals.
January 29, 2021
In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose.
Technology
Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon
New data suggests the vaccine works even better than Pfizer initially reported.
November 18, 2020
I Stock 1154450279
Home
Pfizer Says COVID-19 Vaccine Looks 90% Effective
The data would put the company on track to apply for emergency-use approval from the FDA.
November 9, 2020
A single-dose COVID-19 vaccine being developed by Johnson & Johnson.
Home
Late-Stage Study of First Single-Shot Vaccine Begins in US
U.S. health officials insist the race for a vaccine isn't cutting corners.
September 23, 2020
This photo provided by Novo Nordisk Inc. shows its Tresiba brand insulin. On Tuesday, April 14, 2020, Novo Nordisk announced a new program offering free insulin for at least three months months for diabetes patients who have lost their insurance amid the COVID-19 pandemic.
Operations
Insulin Makers Offer it Free or Cheap
All top three insulin makers are now offering programs to help patients.
April 14, 2020
Johnson's Baby Aloe & Vitamin E Powder in Salt Lake City. Johnson & Johnson reports financial results Tuesday, April 14, 2020.
Economics
J&J Races to Develop Vaccine
The company also cut billions from its forecast on higher related costs and fewer sales.
April 14, 2020
This undated photo provided by the U.S. Attorney's Office shows a phony coronavirus cure that a British man tried to smuggle into the United States. Con artists are finding lots of marks amid the COVID-19 pandemic. Watchdog groups and authorities report a surge of complaints about scams targeting people who fear catching the virus or need money due to lost income.
Safety
COVID-19 Cure Cons Rampant
Americans filed complaints about losses to coronavirus-related fraud totaling nearly $6 million.
April 8, 2020
In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. On Tuesday, March 24, 2020, the U.S. Food and Drug Administration warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions.
Laws & Regulations
EpiPens Could Harm Patients
The malfunctions can prevent or delay the devices from injecting the drug or cause them to eject it prematurely.
March 24, 2020
U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md.
Home
Companies Warned Over Virus Claims
The companies are selling soaps, sprays and other concoctions with false claims that they can treat the new coronavirus or keep people from catching it.
March 10, 2020
This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Health officials reported the first U.S. drug shortage tied to the viral outbreak that is disrupting production in China, but they declined to identify the manufacturer or the product. The Food and Drug Administration said late Thursday, Feb. 27, 2020, that the drug's maker contacted health officials recently about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.
Supply Chain
Drug Shortage Tied to Outbreak
The drug's maker contacted officials about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.
March 2, 2020
I Stock 1135337514
Recalls
Weight Loss Drug Pulled
The company still believes Belviq's benefits outweigh the cancer risk.
February 14, 2020